Heraeus Medical Components, a global business unit of Heraeus Holding GmbH, has executed a share purchase agreement to acquire 100% of the stock in NeoMetrics. NeoMetrics, headquartered in Plymouth, Minnesota, specializes in designing and manufacturing guidewires and components for medical devices. The company's production facilities, in both Minnesota and Costa Rica, include cleanroom manufacturing and extensive guidewire fabrication technologies. Closing of this transaction is expected to occur in the next 60 days.
"With this acquisition, Heraeus Medical Components will add new interventional technologies to augment their leadership position as a sourcing solution for the world's medical device companies. We are excited about the potential growth opportunities within the interventional field," said Dr. Nicolas Guggenheim, President of Heraeus Medical Components. "NeoMetrics' experience in the development of interventional and vascular access guidewires substantially builds upon our existing component capabilities. We plan to use our combined expertise to bring new solutions for our medical device customers."
"We are excited to become part of Heraeus Medical Components," said Dave Liebl, President, NeoMetrics. "Joining Heraeus will allow us to support our continued growth, including the opportunity to introduce our products and expertise to new markets. Both companies share a culture of consistently exceeding customer expectations."
The management team and employees of NeoMetrics will continue as part of Heraeus, contributing important domain expertise and ensuring continuity for customers. Gene Champeau, co-founder and CEO of NeoMetrics will assist Heraeus in developing new business platforms and product strategies on a consulting basis. Heraeus intends to continue operation of both of the NeoMetrics facilities post-closing.
